The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies
Authors
Keywords
-
Journal
NEUROCHEMISTRY INTERNATIONAL
Volume 158, Issue -, Pages 105376
Publisher
Elsevier BV
Online
2022-06-03
DOI
10.1016/j.neuint.2022.105376
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neurobiological Promises of the Bitter Diterpene Lactone Andrographolide
- (2022) Rajib Hossain et al. Oxidative Medicine and Cellular Longevity
- A Selective Histamine H4 Receptor Antagonist, JNJ7777120, Role on glutamate Transporter Activity in Chronic Depression
- (2022) Yesim Yeni et al. Journal of Personalized Medicine
- Ethnobotany, Phytochemistry, Biological Activities, and Health-Promoting Effects of the Genus Bulbophyllum
- (2022) Javad Sharifi-Rad et al. Evidence-based Complementary and Alternative Medicine
- Relationship between risk and protective factors and clinical features of Parkinson's disease
- (2022) Daniele Belvisi et al. PARKINSONISM & RELATED DISORDERS
- ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease
- (2021) Vasileios Siokas et al. Journal of Clinical Medicine
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture
- (2021) Ruth Chia et al. NATURE GENETICS
- Potential of extracellular vesicles in the Parkinson's disease – Pathological mediators and biomarkers
- (2021) Yuan Zhao et al. NEUROCHEMISTRY INTERNATIONAL
- Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
- (2021) Vidar Gundersen Frontiers in Neuroscience
- Thinking Outside the Ischemia Box: Advancements in the Use of Multiple Sclerosis Drugs in Ischemic Stroke
- (2021) Athina-Maria Aloizou et al. Journal of Clinical Medicine
- Parkinson's disease
- (2021) Bastiaan R Bloem et al. LANCET
- Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson's disease: The therapeutic role of Nrf2 activators
- (2021) Saravanan Jayaram et al. NEUROCHEMISTRY INTERNATIONAL
- Tumor Necrosis Factor Inhibition and Parkinson Disease
- (2021) Xiaoying Kang et al. NEUROLOGY
- Role of the Peripheral Nervous System in PD Pathology, Diagnosis, and Treatment
- (2021) Chengxiao Ma et al. Frontiers in Neuroscience
- Parkinson’s disease: A current perspectives on Parkinson’s disease and key bioactive natural compounds as future potential drug candidates
- (2021) Nabeel Ali et al. CURRENT DRUG TARGETS
- Reversal of brain aging by targeting telomerase: A nutraceutical approach
- (2021) Dimitris Tsoukalas et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- A Pharmacological Perspective on Plant-derived Bioactive Molecules for Epilepsy
- (2021) Javad Sharifi-Rad et al. NEUROCHEMICAL RESEARCH
- Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease
- (2021) Tingting Zheng et al. NEUROCHEMISTRY INTERNATIONAL
- Neuropharmacological Effects of Quercetin: A Literature-Based Review
- (2021) Md. Shahazul Islam et al. Frontiers in Pharmacology
- The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?
- (2021) Adina N. MacMahon Copas et al. Frontiers in Neurology
- Search for safer and potent natural inhibitors of Parkinson's disease
- (2021) Sidrah Tariq Khan et al. NEUROCHEMISTRY INTERNATIONAL
- Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson’s Disease
- (2021) Ruichen Su et al. Frontiers in Aging Neuroscience
- Astrocytes, a Promising Opportunity to Control the Progress of Parkinson’s Disease
- (2021) Alberto Sanchez et al. Biomedicines
- The Effect of Silver Nanoparticles on Antioxidant/Pro-Oxidant Balance in a Murine Model
- (2020) Anca Oana Docea et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
- (2020) Ewelina Palasz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson’s Disease Model
- (2020) Perla Ugalde-Muñiz et al. Oxidative Medicine and Cellular Longevity
- Diet, Lifestyle and Cardiovascular Diseases: Linking Pathophysiology to Cardioprotective Effects of Natural Bioactive Compounds
- (2020) Javad Sharifi-Rad et al. International Journal of Environmental Research and Public Health
- Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics
- (2020) Mehdi Sharifi-Rad et al. Journal of Clinical Medicine
- Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells
- (2020) L. Iovino et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Antidiabetic Agents for Treatment of Parkinson’s Disease: A Meta-Analysis
- (2020) Shu-Yi Wang et al. International Journal of Environmental Research and Public Health
- Young Onset Parkinson’s Disease: A Modern and Tailored Approach
- (2020) Bart Post et al. Journal of Parkinsons Disease
- The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation—Evidence from In Vivo Studies
- (2020) Daniela Calina et al. Journal of Clinical Medicine
- Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
- (2020) Marta Pajares et al. Cells
- Inflammatory and Oxidative Stress Markers—Mirror Tools in Rheumatoid Arthritis
- (2020) Radu Răzvan Mititelu et al. Biomedicines
- Clinical Features of Parkinson’s Disease: The Evolution of Critical Symptoms
- (2020) Csaba Váradi Biology-Basel
- Microglia and astrocyte dysfunction in parkinson's disease
- (2020) Tae-In Kam et al. NEUROBIOLOGY OF DISEASE
- The Therapeutic Potential of Anthocyanins: Current Approaches Based on Their Molecular Mechanism of Action
- (2020) Bahare Salehi et al. Frontiers in Pharmacology
- Pharmacological Activities of Psoralidin: A Comprehensive Review of the Molecular Mechanisms of Action
- (2020) Javad Sharifi-Rad et al. Frontiers in Pharmacology
- Neuroinflammatory responses in Parkinson’s disease: relevance of Ibuprofen in therapeutics
- (2020) Ashish Singh et al. INFLAMMOPHARMACOLOGY
- Pesticide use and incident Parkinson's disease in a cohort of farmers and their spouses
- (2020) Srishti Shrestha et al. ENVIRONMENTAL RESEARCH
- Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
- (2020) Hyuk Sung Kwon et al. Translational Neurodegeneration
- Neuroinflammation and protein pathology in Parkinson’s disease dementia
- (2020) Antonina Kouli et al. Acta Neuropathologica Communications
- Parkinson's Disease and the Environment
- (2019) Nicole Ball et al. Frontiers in Neurology
- Parkinson’s Disease in Women and Men: What’s the Difference?
- (2019) Silvia Cerri et al. Journal of Parkinsons Disease
- Non-motor symptoms in Parkinson's disease: An explorative network study
- (2019) Gwenda Engels et al. PARKINSONISM & RELATED DISORDERS
- Prion-Like Mechanisms in Parkinson’s Disease
- (2019) Jiangnan Ma et al. Frontiers in Neuroscience
- A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse
- (2019) Tsatsakis et al. Journal of Clinical Medicine
- Oxidative Stress and Inflammation Interdependence in Multiple Sclerosis
- (2019) Rodica Padureanu et al. Journal of Clinical Medicine
- Genetic risk factors in Parkinson’s disease
- (2018) K. J. Billingsley et al. CELL AND TISSUE RESEARCH
- Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions
- (2018) Gregory S. Calip et al. INTERNATIONAL JOURNAL OF CANCER
- Pathological role of lipid interaction with α-synuclein in Parkinson's disease
- (2018) Mari Suzuki et al. NEUROCHEMISTRY INTERNATIONAL
- Anti–Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
- (2018) Inga Peter et al. JAMA Neurology
- Non-Motor Symptoms of Parkinson’s Disease and Their Impact on Quality of Life in a Cohort of Moroccan Patients
- (2018) Houyam Tibar et al. Frontiers in Neurology
- Astrocytes, Microglia, and Parkinson's Disease
- (2018) Eun-Hye Joe et al. Experimental Neurobiology
- The genetic landscape of Parkinson's disease
- (2018) A. Lunati et al. REVUE NEUROLOGIQUE
- Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
- (2018) Fatemeh N. Emamzadeh et al. Frontiers in Neuroscience
- Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons
- (2018) Sarah A. McClymont et al. AMERICAN JOURNAL OF HUMAN GENETICS
- TNF superfamily member APRIL enhances midbrain dopaminergic axon growth and contributes to the nigrostriatal projection in vivo
- (2017) Thomas G. McWilliams et al. EXPERIMENTAL NEUROLOGY
- Parkinson’s Disease: From Pathogenesis to Pharmacogenomics
- (2017) Ramón Cacabelos INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging
- (2017) Lilach Soreq et al. Cell Reports
- An update on the diagnosis and treatment of Parkinson disease
- (2016) Philippe Rizek et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Normalization of Overexpressed α-Synuclein Causing Parkinson's Disease By a Moderate Gene Silencing With RNA Interference
- (2015) Masaki Takahashi et al. Molecular Therapy-Nucleic Acids
- Tumor Necrosis Factor Alpha: A Link between Neuroinflammation and Excitotoxicity
- (2014) Gabriel Olmos et al. MEDIATORS OF INFLAMMATION
- Evidence of Inflammatory System Involvement in Parkinson’s Disease
- (2014) Yinxia Chao et al. Biomed Research International
- Genetics of Parkinson's Disease
- (2013) C. Klein et al. Cold Spring Harbor Perspectives in Medicine
- Parkinson’s disease-associated mutations in α-synuclein and UCH-L1 inhibit the unconventional secretion of UCH-L1
- (2011) Chiho Konya et al. NEUROCHEMISTRY INTERNATIONAL
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
- (2009) Malú G. Tansey et al. NEUROBIOLOGY OF DISEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started